BioMed Research International / 2009 / Article / Fig 5

Methodology Report

Methyl-CpG-Binding PCR of Bloodspots for Confirmation of Fragile X Syndrome in Males

Figure 5

Representative males examined with (a) screening PCR, (b) Southern blot hybridization, and (c) methyl-CpG-binding PCR. For the non-FXS samples, the CGG repeat numbers are 29 (lanes 1 and 6), 54 (lane 2), and 98 (lane 3). For the FXS samples, lane 4 is a mosaic pattern comprising expanded FMR1 alleles with and without methylation, and unmethylated alleles with CGG-repeats in the normal range (indicated by arrows), and lane 5 has a nonmosaic pattern. (M): molecular size markers.
643692.fig.005a
(a)
643692.fig.005b
(b)
643692.fig.005c
(c)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.